Latest News

A clinical trial of CAR-T cell therapy developed at Hollings has received NCI funding to expand.

An Ewing sarcoma researcher at MUSC is one of three scientists nationwide to receive a career development award from the Rally Foundation.

Hollings researchers use patented technology to improve immunotherapy by prolonging survival of cancer-fighting T-cells.

Hollings is a pilot site for an American Cancer Society program to train college students to navigate patients to needed resources.

Head and neck cancer surgeons at Hollings are testing a fluorescent dye that illuminates nerves, which should make them easier to find during surgery.

Through years of heartache and hard work, widower raises funds for research into the cancer that took his wife.

The National Cancer Institute renewed MUSC Hollings Cancer Center's NCI designation, awarding the center its best score ever of “outstanding performance.”

Is there a role for e-cigarettes among adults who have not been able to stop using combustible cigarettes after using FDA-approved medication?

Working with people with brain tumors brings great satisfaction to South Carolina's only neuro-oncologists.

Three MUSC occupational therapy students are passionate about elevating the profession's role in cancer care.